BACKGROUND
SlowMo is a digitally supported therapy for paranoia that was developed using inclusive, human-centred design to improve outcomes and address barriers to implementation. SlowMo significantly improved paranoia and wellbeing compared to treatment as usual in a recent randomised controlled trial of 362 people with psychosis.
OBJECTIVE
This study evaluates whether the design was effective in optimising the user experience of the SlowMo mobile app for a diverse range of people.
METHODS
Digital literacy, adherence (via system analytics and self-report) and user experience were assessed, and investigated in relation to demographics (i.e. gender, age, ethnicity, paranoia severity).
RESULTS
81% of therapy completers met the a priori analytics adherence criteria. Technology use and confidence was lower in Black people and older people. However, analytics adherence did not differ by demographics. High rates of user experience were reported overall (75%, SD = 17.06), although self-reported app use, enjoyment and usefulness were higher in women than men. No differences were found for ethnicity, age or paranoia severity.
CONCLUSIONS
The SlowMo therapy design overcame the ‘digital divide’ in the user experience of psychosis therapies, validating the importance of employing human-centred design when developing therapeutics. SlowMo may address implementation barriers for minoritised groups of people with psychosis. It should be further developed and tested in the NHS.
CLINICALTRIAL
ISRCTN32448671